Literature DB >> 16575667

[Distal extremity reconstruction for limb salvage in diabetic foot ulcers with pedal bypass, flap plasty and vacuum therapy].

W Lang1, R E Horch.   

Abstract

There are numerous factors resulting in tissue damage and foot ulcers in diabetic patients. Critical ischaemia should be routinely excluded and an examination of the limb perfusion must be done in all cases with clinical suspicion of reduced perfusion. Pedal bypass grafting procedures in combination with flap plasty techniques achieve good results in patients with non-healing diabetic ulcers. Timing of the procedure is essential to avoid progression of gangrene. Good results of pedal bypass grafts support an indication at an early stage. Vacuum assisted wound therapy and local wound surgery can be done first to prepare patients with septic foot lesions for two-staged procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16575667     DOI: 10.1055/s-2006-921472

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

1.  Distal pedal bypasses combined with free microsurgical flaps in chronic limb ischaemia for problematic wounds.

Authors:  Raymund E Horch; Werner Lang; Alexander Meyer; Marweh Schmitz
Journal:  Int Wound J       Date:  2014-05-02       Impact factor: 3.315

2.  [Economic aspects of surgical wound therapies].

Authors:  R E Horch; D Nord; M Augustin; G Germann; M Leffler; A Dragu
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

3.  Limb salvage procedure in immunocompromised patients with therapy-resistant leg ulcers-The value of ultra-radical debridement and instillation negative-pressure wound therapy.

Authors:  Alexander Geierlehner; Raymund E Horch; Wibke Müller-Seubert; Andreas Arkudas; Ingo Ludolph
Journal:  Int Wound J       Date:  2020-06-22       Impact factor: 3.315

Review 4.  Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science.

Authors:  E Polykandriotis; A Arkudas; R E Horch; M Stürzl; U Kneser
Journal:  J Cell Mol Med       Date:  2007 Jan-Feb       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.